Status:
COMPLETED
Assessment of Walking-related Fatigability in Patients With Multiple Sclerosis.
Lead Sponsor:
Hasselt University
Collaborating Sponsors:
Revalidatie & MS Centrum Overpelt
National MS Center Melsbroek
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The primary goal of this interventional study is to objectively examine the prevalence of walking-related performance fatigability, together with the psychometric properties of its measuring parameter...
Eligibility Criteria
Inclusion
- Age between 18 - 70 years
- Confirmed diagnosis according to the McDonald criteria
- Performed a 6MWT before, to ensure familiarization
- Able to walk independently or with unilateral support for 6 minutes without rest
- Signed the informed consent
Exclusion
- Exacerbation or relapse within last 3 months before study
- Other neurological diagnosis, such as stroke and Parkinson
- MS-like syndromes, such as neuromyelitis optica
- Other medical condition interfering with walking ability (e.g. cardiac or respiratory diseases, arthritis and fibromyalgia)
Key Trial Info
Start Date :
December 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2018
Estimated Enrollment :
85 Patients enrolled
Trial Details
Trial ID
NCT03860675
Start Date
December 1 2017
End Date
May 31 2018
Last Update
March 4 2019
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Hasselt University
Diepenbeek, Belgium, 3590
2
National MS Center Melsbroek
Melsbroek, Belgium, 1820
3
Revalidatie & MS Centrum Overpelt
Overpelt, Belgium, 3900